Management of diffuse large B‑cell lymphoma in older adults: current strategies and emerging directions
Therapeutic Advances in Medical Oncology
Published online on June 26, 2026
Abstract
Therapeutic Advances in Medical Oncology, Volume 18, January-December 2026.
Diffuse large B-cell lymphoma (DLBCL) is the most common subtype of malignant lymphoma in older adults. Treatment in this population remains challenging due to heightened genetic heterogeneity and reduced physiological reserve, which increase ...
Diffuse large B-cell lymphoma (DLBCL) is the most common subtype of malignant lymphoma in older adults. Treatment in this population remains challenging due to heightened genetic heterogeneity and reduced physiological reserve, which increase ...